A Breakthrough in Stroke Rehabilitation: Non-Invasive Biophoton Therapy Promotes Neurofunctional Recovery in Chronic Stroke Patients
DOI:
https://doi.org/10.47363/JADR/2025(2)108Keywords:
Chronic Stroke, Biophoton Therapy, Neuroregeneration, Quantitative Eeg, Event-Related Potentials, Brain Energy, Mapping, Non-Linear Diagnostics, Stroke Rehabilitation, Energy MedicineAbstract
Background: Effective treatments for chronic stroke remain a critical unmet medical need. Conventional rehabilitation approaches often yield limited functional recovery, especially in patients with long-standing deficits. Emerging evidence suggests that biophoton-based therapies may offer a novel, noninvasive solution to support neuroregeneration.
Objective: To evaluate the therapeutic efficacy and safety of Automatic Biophoton Generators (ABGs) in patients with chronic stroke using validated clinical, neurological, and neurophysiological outcome measures.
Methods: A randomized, triple-blind, placebo-controlled clinical trial was conducted with 46 chronic stroke patients who received either active ABG
treatment (n = 26) or placebo devices (n = 20) over two weeks. Participants in the placebo group were later crossed over to receive active treatment for
an additional four weeks. Each treatment group received therapy with 4 ABGs placed around a hotel bed. Stroke recovery was assessed using the Stroke Impact Scale (SIS), SF-36 quality-of-life survey, clinician-led neurological examinations, and quantitative Electroencephalography (qEEG) with Event- Related Potentials (ERP). Additional evaluations included 3D Non-Linear Scanning (3D-NLS) for energetic brain imaging and Bio-Well analysis for organ and meridian energy coherence.
Results: Biophoton therapy resulted in statistically significant improvements in SIS scores, stroke recovery rate, neurological exam scores, and quality-oflife measures (p < 0.01). qEEG revealed increased posterior alpha frequencies, reduced theta/beta ratios, and improved ERP latencies, indicating enhanced attention, memory processing, and cognitive speed. 3D-NLS imaging showed rapid cortical reactivation and restored hemispheric balance after only 6 days of therapy. Bio-Well analysis demonstrated systemic energy restoration across the brain, cardiovascular system, and endocrine organs. No adverse events were reported.
Conclusion: This study provides strong clinical and neurophysiological evidence that ABG-based biophoton therapy significantly improves functional outcomes in patients with chronic stroke. The therapy was well tolerated and offers a promising, non-invasive approach to address long-standing neurological impairments. These findings support the broader potential of biophoton quantum therapy in treating neurodegenerative and chronic inflammatory disorders.